<DOC>
	<DOCNO>NCT01005043</DOCNO>
	<brief_summary>The primary objective trial determination feasibility toxicity Heavy Ion Radiotherapy ( C12 ) patient non-resectable osteosarcoma . Secondary endpoint tumor response , disease free survival overall survival . The aim improve outcome patient non-resectable osteosarcoma .</brief_summary>
	<brief_title>Therapy Trial Determine Safety Efficacy Heavy Ion Radiotherapy Patients With Osteosarcoma</brief_title>
	<detailed_description>Osteosarcoma common primary malignant bone tumor child adolescent . For effective treatment , local control tumor absolutely critical , chance long term survival &lt; 10 % might effectively approach zero complete surgical resection tumor possible . Up date curative treatment protocol patient non-resectable osteosarcoma , exclude current osteosarcoma trial , e.g . EURAMOS1 . Local photon radiotherapy previously use small series uncontrolled , highly individualized fashion , , however , document high dose radiotherapy , principle , use achieve local control . Generally radiation dose necessary curative approach hardly achieve conventional photon radiotherapy patient non-resectable tumor usually locate near radiosensitive critical organ brain , spine pelvis . In case Heavy Ion Radiotherapy ( HIT ) may offer promise new alternative . Moreover , compare photon , heavy ion particle provide high physical selectivity finite depth coverage tissue . They achieve high relative biological effectiveness . Phase I/II dose escalation study HIT adult non-resectable bone soft tissue sarcoma already show favorable result . Methods/Design : This monocenter , non-randomized study patient older 6 year age non-resectable osteosarcoma . Desired target dose 60-66 Cobalt Gray Equivalent ( GyE ) . Weekly fractionation 6 x 3 Gy E use . HIT administer exclusively Ion Radiotherapy Center Heidelberg . Furthermore , FDG-PET image characteristic non-resectable osteosarcoma HIT investigate prospectively . Systemic disease HIT target standard chemotherapy protocol part trial . The primary objective trial determination feasibility toxicity HIT . Secondary endpoint tumor response , disease free survival overall survival . The aim improve outcome patient non-resectable osteosarcoma .</detailed_description>
	<mesh_term>Osteosarcoma</mesh_term>
	<criteria>Histological diagnosis high grade osteosarcoma without metastasis Nonresectable tumor pelvis , skull base spine , respectively , incomplete intralesional tumor resection confirm evaluation two orthopedic surgeon ( respectively neurosurgeon case spine tumor ) : one local surgeon one referee surgeon University Heidelberg . Age old 6 year start radiotherapy Adequate performance status ( Karnofsky &gt; 60 % ) Adequate blood cell production start HIT patient pelvic spine tumor define : total white cell count ( WBC ) &gt; 1,0/nl ; neutrophil &gt; 200/µl ; platelet count &gt; 20/nl No febrile neutropenia ( neutrophils &lt; 200/µl ) Written informed consent patient legal guardian Nonresectable tumor site mean primary tumor affect anatomic area human body surgical total resection ( R0 ) tumor possible technical reason , example osteosarcoma pelvis , spine skull base . In case , surgical resection recommend . Nonresectability confirm evaluation two orthopedic surgeon ( respectively neurosurgeon case spine tumor ) : one local surgeon one referee surgeon University Heidelberg . In case surgery tumor might possible HIT . Then recommend surgical resection residual tumor afterwards . Age young 6 year Previous radiotherapy field radiate Implanted metal within plan radiation field , lead significant artefact within target volume Patients receive investigational agent time HIT Performance status ( Karnofsky ) &lt; 60 % ) Pregnancy No write informed consent patient legal guardian</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>non-resectable osteosarcoma</keyword>
	<keyword>heavy ion radiotherapy</keyword>
	<keyword>particle therapy</keyword>
	<keyword>safety</keyword>
	<keyword>toxicity</keyword>
	<keyword>survival</keyword>
	<keyword>radiotherapy</keyword>
</DOC>